The Role of Endothelin-1 in Sickle Cell Disease

NCT02712346 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

DRUG: Ambrisentan
DRUG: Placebo

Sponsor

Augusta University

Collaborators

[object Object]
[object Object]